Get key insights from Chemed’s Q3 2025 earnings call—performance trends, margin recovery, and company outlook for VITAS & Roto-Rooter.
Chemed’s third quarter was marked by continued operational challenges in both the VITAS and Roto-Rooter businesses, resulting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback